Navigation Links
Fourth Annual EagleBank Foundation Fight Breast Cancer Golf Classic Raises Over $100,000
Date:11/13/2008

BETHESDA, Md., Nov. 13 /PRNewswire/ -- The fourth annual EagleBank Foundation Fight Breast Cancer Golf Classic raised over $100,000. The following local hospitals were the primary beneficiaries: Shady Grove Adventist Hospital and Suburban Hospital in Montgomery County, MD, and The George Washington University Hospital, Providence Hospital and Washington Hospital Center in Washington, DC. Another beneficiary was the Primary Care Coalition of Montgomery County. The tournament was held on October 13, 2008, at the Woodmont Country Club. Hospital representatives were present at the event to accept their donation checks.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050927/EAGLEBANKLOGO )

"We are again proud of our efforts to raise funds to help fight the devastating effects that breast cancer has on all who are touched by it," commented Donald R. Rogers (of Shulman, Rogers, Gandal, Pordy & Ecker, P.A.), a director of EagleBank and the Chairman of the EagleBank Foundation. "Because of the tremendous generosity of our sponsors, players, contributors and volunteers, we are proud to provide this much-needed funding for breast cancer programs and services at these well-deserving local hospitals. It was an honor working with so many wonderful, dedicated people with the same commitment and focus," he concluded.

"As a local, business bank, this annual event brings us in contact with many others who share our commitment to the community," commented EagleBank's Chairman and CEO Ronald D. Paul. "We could not do it alone. Working with employees, board members and their spouses, vendors and suppliers, the hospitals, and our generous sponsors, donors and players, we successfully raised over $100,000, despite these very difficult and uncertain financial times. We're proud of these efforts and sincerely thank everyone involved. We look forward to next year and another chance
'/>"/>

SOURCE EagleBank Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. NBTY Reports Fourth Quarter and Fiscal Year Results
2. Hologic Announces Fourth Quarter and Fiscal 2008 Operating Results
3. Hillenbrand, Inc. Announces Fourth-Quarter Earnings Release Date and Conference Call
4. Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales
5. Malibu Alcohol and Drug Rehab Center Celebrates Fourth Anniversary
6. MSA Declares Fourth Quarter Dividend
7. BD Announces Results for Fourth Fiscal Quarter and Full Year
8. MedCath Corporation to Hold Conference Call on Fourth Quarter Results
9. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Fourth Quarter and Year End Earnings Webcast
10. Veterinary Pet Insurance Kicks Off Fourth Annual Pet Cancer Awareness Month
11. Rochester Medical Announces Fourth Quarter 2008 Earnings Conference Call November 6, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...tudy finds gene variation believed to affect circa...ealthDay News) -- New research suggests that an in...a factor in the development of bipolar disorder in...ination of the genetic makeup of 152 children with...le to major mood swings, and 140 children without ...
(Date:11/27/2009)... Biotech firm Replikins Lt... the H1N1 virus genomic data. It shows that the l... 3.7 (s.d. 4.5) during the virus,s current outbrea...vels this week of 2.0 (s.d. 0.1). The H1N1 infecti... Boston (PRWEB) November 27, 2009 ...
(Date:11/27/2009)..., , NEUILLY-SUR-SEINE, France, Nov. 27 /P...erican professional cycling team dedicated to ethi... cycling champions, announced today that it will b... Transitions Optical as a new sponsor of the team....cturer of adaptive eyewear, offering the most adva...
(Date:11/27/2009)...oaring rates to bring unprecedented medical, econo...Nov. 27 (HealthDay News) -- The number of people w...ouble over the next 25 years, a new study predicts... 44.1 million people with the disease, up from 23....of treating people with diabetes will triple, the ...
(Date:11/27/2009)... Specialist manufacturers ...roducts are saving millions of dollars by bringing... process. Increasing numbers of pro-active medical...perts at the concept stage of their projects, ensu...ting design processes or potentially outdated tech...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...archers at the Harvard Medical School it is said t... chronically infected cystic fibrosis (CF) patient...which secretes proteins that cause disease in the ...ay be a cancer patient with a weakened immune syst...
...on placed new restrictions on a doctors’ role i...st any policy //that gives medical professionals ...to use harsher tactics than they would in the abs...roups and medical ethicists. They charge that doct...
...ar excuse "not tonight, I have a headache," a new ...xual activity and says that sexual desire and migr... // In fact, migraine sufferers reported hig...eagues. 'Migraine patients in general may exp...
...lthcare products Regulatory Agency (MHRA) warned t...eadings. The diabetic patients are cautioned about...d to giving readings which were far too high. Diab...nsulin resulting in hypoglycaemic coma. It is...
...in San Diego, California, Allerca, Inc., is now t...kitten, the world’s first hypoallergenic cats //.T...o are also cat lovers. Allerca sources claim ...ng. Hence these animals were not transgenic,in oth...
...s at the Johns Hopkins Bloomberg School of Public ...lar immune tactics to ward off bacterial// pathoge...wn on the different genes connected with the prote...rtant for the resistance to bacterial infection. H...
Other Medicine News:Health News:Treatment of Bacterial Infection Paves the Way to Treat CF Infection 2Health News:Medical Role In Interrogations Curtailed By Pentagon 2Health News:What Ticks the Mosquito immune system? 2
(Date:11/25/2009)... , WALTHAM, Mass., Nov. 25 Acc...bal authority on medical technology market intelli...fixation devices will continue to see rapid growth...mic slowdown. MRG,s US Markets for Trauma Devices... highly dynamic over the next five years, with com...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Reportlin...t is available in its catalogue: ,, Intranasal... http://www.reportlinker.com/p0164267/Intranasal-D..., The US intranasal drug delivery market is witn...om the delivery of conventional local therapeutic ...
(Date:11/24/2009)... , BETHESDA, Md., Nov. 24 /PRNewswire-Asia/...q: CHDX ), a leading independent American provide...he People,s Republic of China, today,announced tha...ffray,"Unplugged" Health Care Conference, to be he...tel. , Management is currently scheduled ...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2Indiana Drug Card to Provide Free Drug Cards to Residents 53014 1Indiana Drug Card to Provide Free Drug Cards to Residents 53014 2Human Genome Sciences Announces Pricing of Public Offering of Common Stock 13237 1Human Genome Sciences Announces Pricing of Public Offering of Common Stock 13237 2Human Genome Sciences Announces Pricing of Public Offering of Common Stock 13237 3Tanning Beds Get Highest Carcinogen Rating 53009 1Tanning Beds Get Highest Carcinogen Rating 53009 2Tanning Beds Get Highest Carcinogen Rating 53009 3
...ath by 13% (P=0.08), despite inclusion of patients... , - In a separate censored analysis excluding...tion in risk of death was 19% , , - Long-term...einforces starting with Femara as the optimal trea...VER, N.J., Dec. 11 New long-term data from a majo...
...Jersey and PHILADELPHIA, December 11, Rosetta Geno...icroRNA-based molecular diagnostics, announced tod...stic test, miRview(TM) squamous.,The test is now c...A-certified lab in Philadelphia. , To order ...r visit the,company,s website http://www.rosettag...
Other Medicine Technology:Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 2Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 3Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 4Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 5Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 6Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 7Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 8Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 2Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 3Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 4Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 5
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: